Building a business is a team sport. As investors, we don’t just sit on the sidelines but do whatever it takes to help our teams win.
The founders we back don’t limit themselves to what is, but relentlessly pursue what could be. We invest in transformative technology companies that are changing the way we live and work.
Menlo Labs starts companies. We work shoulder-to-shoulder alongside visionary founders to help groundbreaking ideas break ground.
When we’re in, we’re ALL IN. From our partners to our Fuel team, we are deeply committed to our companies as they navigate every stage of growth.
Developers have become increasingly powerful decision makers and influencers within organizations, with purchasing powers of their own and dedicated budgets—particularly in light of the explosive growth of GenAI.
Founder Devin Bhushan talks about Squint and making the leap to entrepreneurship with the help of Menlo Labs.
Today, Squint revealed an impressive roster of customers that includes Volvo and Siemens, and announced $6 million in seed and pre-seed funding from Sequoia Arc, Menlo Ventures, and Menlo Labs.
Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.
